ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 171 filers reported holding ESPERION THERAPEUTICS INC NE in Q4 2022. The put-call ratio across all filers is 0.24 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,219,072 | +273.2% | 2,264,359 | +429.3% | 0.01% | +333.3% |
| Q2 2023 | $594,631 | +140.5% | 427,792 | +175.1% | 0.00% | +50.0% |
| Q1 2023 | $247,250 | -72.8% | 155,503 | +6.5% | 0.00% | -66.7% |
| Q4 2022 | $909,699 | -0.3% | 146,019 | +316.3% | 0.01% | -25.0% |
| Q4 2020 | $912,000 | -29.8% | 35,072 | +0.3% | 0.01% | -38.5% |
| Q3 2020 | $1,299,000 | -34.5% | 34,952 | -9.5% | 0.01% | -38.1% |
| Q2 2020 | $1,982,000 | +64.8% | 38,620 | +1.2% | 0.02% | +40.0% |
| Q1 2020 | $1,203,000 | -51.1% | 38,159 | -7.5% | 0.02% | -37.5% |
| Q4 2019 | $2,460,000 | +107.8% | 41,247 | +27.7% | 0.02% | +60.0% |
| Q3 2019 | $1,184,000 | -18.0% | 32,310 | +4.1% | 0.02% | -25.0% |
| Q2 2019 | $1,444,000 | +13.3% | 31,050 | -2.1% | 0.02% | +11.1% |
| Q1 2019 | $1,274,000 | +239.7% | 31,720 | +289.2% | 0.02% | +157.1% |
| Q4 2018 | $375,000 | +7.8% | 8,150 | +3.8% | 0.01% | +40.0% |
| Q3 2018 | $348,000 | +11.2% | 7,850 | -57.6% | 0.01% | -28.6% |
| Q1 2016 | $313,000 | – | 18,500 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 4,468,835 | $22,344,000 | 10.09% |
| Altium Capital Management LP | 2,515,785 | $12,579,000 | 3.47% |
| Deep Track Capital, LP | 5,641,668 | $28,208,000 | 1.99% |
| Paradigm Biocapital Advisors LP | 839,257 | $4,196,000 | 1.20% |
| SABBY MANAGEMENT, LLC | 940,400 | $4,702,000 | 0.68% |
| Monaco Asset Management SAM | 500,000 | $2,500,000 | 0.62% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 5,000,000 | $25,000,000 | 0.52% |
| CVI Holdings, LLC | 1,460,595 | $7,303,000 | 0.48% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 2,713,176 | $13,566,000 | 0.38% |
| Rhenman & Partners Asset Management AB | 1,000,000 | $4,960,000 | 0.33% |